Multiple sclerosis Trials in Cleveland, United States
Conditions / Multiple sclerosis / Cleveland, United States
Research into Multiple sclerosis spans multiple therapeutic approaches and trial phases.
66 total trials for this combination
Showing top 10 of 66 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00340834 | Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase | COMPLETED | PHASE3 |
| NCT03567057 | A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment | COMPLETED | PHASE3 |
| NCT04548999 | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03436199 | Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment | COMPLETED | PHASE3 |
| NCT02936037 | Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) | TERMINATED | PHASE3 |
| NCT03387267 | Videofluoroscopic Swallowing Study (VFSS) | TERMINATED | NA |
| NCT02047097 | Dimethyl Fumarate (DMF) Observational Study | COMPLETED | — |
| NCT01776034 | Health Promotion and Wellness Program for Adults With Disabling Conditions | COMPLETED | NA |
| NCT00605215 | BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) | COMPLETED | PHASE3 |
| NCT02833311 | e-Mobile Tablet for People With Chronic Conditions | COMPLETED | NA |